Intercept Pharmaceuticals, Inc. (“Intercept”), a biopharmaceutical company based in Morristown, New Jersey, has filed a notice of data breach with the Attorney General of Massachusetts after discovering unauthorized access to confidential information entrusted to the company. The breach, revealed on February 22, 2024, resulted in the exposure of consumers’ sensitive data, including their names, Social Security numbers, medical records, financial account information, and driver’s license numbers.
Upon uncovering the breach, Intercept promptly initiated an investigation to ascertain the extent and nature of the incident. The investigation confirmed that an unauthorized party had accessed certain files containing confidential consumer information. Subsequently, Intercept undertook a review of the compromised files to identify the specific information leaked and the affected consumers.
In response to the breach, Intercept Pharmaceuticals began sending out data breach notification letters to all individuals whose information was compromised in the incident. These letters aim to provide affected individuals with details regarding the compromised information.
Given the seriousness of the breach and the potential risks involved, individuals who received data breach notifications from Intercept Pharmaceuticals are advised to take necessary precautions to protect themselves from potential fraud or identity theft. Seeking guidance from a data breach lawyer can be beneficial in understanding one’s rights and exploring legal options following the Intercept Pharmaceuticals data breach.
